Cancer Screening More Likely After a Previous False Positive

Share this content:
Cancer Screening More Likely After a Previous False Positive
Cancer Screening More Likely After a Previous False Positive

MONDAY, April 23, 2018 (HealthDay News) -- Patients who previously had a false-positive breast or prostate cancer screening test result are more likely to have future screenings, according to a study published online April 23 in Cancer.

Glen B. Taksler, Ph.D., from the Cleveland Clinic, and colleagues assessed whether 92,405 individuals aged 50 to 75 years (2006 to 2015) were up-to-date with their breast, prostate, or colorectal cancer screening. Differences in current status were assessed by whether patients had a previous false-positive test result.

The researchers found that women were more likely to be up-to-date with breast cancer screening if they previously had false-positive mammography results both without breast biopsy (adjusted odds ratio [aOR], 1.43) and with breast biopsy (aOR, 2.02; both P < 0.001). These same women were also more likely to be current for colorectal cancer screening (aOR range, 1.25 to 1.47, depending on breast biopsy; both P < 0.001). Similarly, men who previously had false-positive prostate cancer test results were more likely to be current with colorectal cancer screening (aOR without prostate imaging/biopsy, 1.22 [P = 0.039] and aOR with imaging/biopsy, 1.60 [P = 0.028]).

"Prior experience with cancer screenings may influence a patient's willingness to continue future screening," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »